 The objective of the SOFA trial is to investigate whether supplemental intake of n-3 polyunsaturated fatty acids n-3 PUFA from fish oil can reduce the recurrence of life-threatening ventricular arrhythmias in patients with an implantable cardioverter defibrillator ICD. 